Press Releases
RRC Introducing The next-generation in chemical-free moisture analysis Computrac...
Arizona Instrument LLC is proud to announce the release of the Computrac® Vapor Pro® XL – the latest in a long line of accurate, reliable...
Press Releases
FDA Approves Troxyca ER Capsules with Abuse-Deterrent Properties for...
Pfizer Inc announced that the U.S. Food and Drug Administration (FDA) has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules, for oral use,...
Press Releases
AstraZeneca provides update on Phase III trial of Selumetinib...
 AstraZeneca announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in combination with docetaxel chemotherapy as 2nd-line treatment in...
Press Releases
Biogen Announces Bioverativ as Name of New Hemophilia-Focused Company
Biogen announced that Bioverativ will be the name of the standalone, publicly-traded global biotechnology company that it expects to launch in early 2017. Bioverativ will...
Press Releases
Takeda Receives Marketing Authorization in Canada for NINLAROâ„¢ (ixazomib)...
Takeda Pharmaceutical Company Limited announced Takeda Canada has received approval from Health Canada for NINLAROâ„¢ (ixazomib) capsules in combination with lenalidomide and dexamethasone for the...
Press Releases
FDA Approves Mercks KEYTRUDA® for Patients with Recurrent or...
Merck known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the company’s...
Press Releases
Teva Announces Launch of Generic Gleevec® Tablets in the...
Teva Pharmaceutical Industries Ltd announced the launch of the generic equivalent to Gleevec®1(imatinib mesylate) tablets,100 mg and 400 mg, in the United States for multiple...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.